Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Merck & Co. provides update on anti-HIV drug development

July 25, 2012

Collaborating organizations in Belgium and France patent new agents for AIDS

July 24, 2012

Janssen submits application for new formulation of anti-HIV agent in Japan

July 23, 2012

NIH to test maraviroc-based drug regimens for HIV prevention

July 20, 2012

FDA approves drug to reduce risk of HIV infection

July 17, 2012

French scientists patent novel agents for AIDS

July 17, 2012

Bristol-Myers Squibb patents new agents for HIV infection

July 16, 2012

NIH awards funding for HIV vaccine research

July 13, 2012

Shionogi-ViiV Healthcare discloses initial data from SINGLE trial

July 11, 2012

Norwegian government awards grant to Bionor

July 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...